New research suggests glp 1 weight loss drugs may assist heart recovery by restoring microvascular blood flow

New Bristol and UCL research shows GLP 1 drugs like Ozempic can reopen tiny blood vessels to prevent heart failure after a heart attack.

By: AXL Media

Published: Mar 5, 2026, 3:24 AM EST

Source: The information in this article was sourced from University of Bristol

Potential for Repurposing Weight Loss Medications

Popular medications originally designed for weight management and type 2 diabetes may soon play a critical role in emergency cardiac care. Research led by the University of Bristol and University College London has found that GLP 1 receptor agonists, including semaglutide and tirzepatide, offer significant protective benefits for the heart immediately following a myocardial infarction. These findings, published in the journal Nature Communications, suggest that the drugs could be repurposed to address complications that currently affect up to fifty percent of heart attack survivors, potentially reducing long term mortality rates.

Addressing the No Reflow Complication

The primary focus of the study is a condition known as no reflow, which occurs when blood fails to reach certain areas of the heart tissue even after a major blocked artery has been successfully reopened by surgeons. This complication is a major driver of post attack hospitalizations and heart failure. Researchers discovered that while emergency medical treatments focus on the primary coronary arteries, the tiny capillaries within the heart muscle often remain narrowed or blocked. This persistent lack of oxygen rich blood leads to irreversible tissue damage and significantly increases the risk of death within one year of the initial cardiac event.

The Role of Pericytes in Cardiac Ischemia

The biological mechanism behind this narrowed blood flow involves specialized contractile cells called pericytes. During the early stages of ischemia, these cells tighten around the coronary capillaries, acting like a vice that prevents blood from flowing through the microvasculature. Dr. Svetlana Mastitskaya, the lead author from Bristol Medical School, explained that these tiny vessels are essential for total heart recovery. The latest data reveals that GLP 1 drugs specifically counteract this constriction, allowing the capillaries to relax and reopen when they would otherwise remain shut.